Professional
Added to YB: 2024-09-02
Pitch date: 2024-09-01
LFCR [bullish]
Lifecore Biomedical, Inc.
+62.79%
current return
Author Info
No bio for this author
Company Info
Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization that serves customers in the United States, Belgium, the Netherlands, and internationally.
Market Cap
$276.5M
Pitch Price
$4.30
Price Target
25.00 (+246%)
Dividend
N/A
EV/EBITDA
-122.20
P/E
-5.79
EV/Sales
3.45
Sector
Life Sciences Tools and Services
Category
turnaround
Betting on a Rebound: Why Lifecore Biomedical Could Triple in Value
LFCR: CDMO with $40-50m EBITDA potential. Recent headwinds: no sale, delayed filings, debt issues, poor guidance. But capacity ramping, filings current, new management. $15-25 price target on reasonable multiples. High demand for CDMO assets. Current price <$5 offers intriguing risk/reward.
Read full article (1 min)